A database for retrieving information on SARS-CoV-2 S protein mutations based on correlation network analysis

BMC Genomic Data

Table 1 Geographical locations of SARS-CoV-2 specimens and cases

Nation	Specimens (S)	Cases (C)	Ratio (S/C)
United States	1,816,065	73,958,288	2.4%
United Kingdom	1,307,360	17,405,439	7.5%
Germany	276,777	9,978,146	2.7%
Switzerland	99,615	2,268,533	4.3%
Australia	13,312	2,182,390	0.6%
Slovakia	10,409	1,022,784	1.0%
Iceland	5,365	67,594	7.9%
Bahrain	4,946	374,575	1.3%
Kenya	4,013	321,381	1.2%
Mexico	2,950	5,198,891	< 0.1%
Denmark	2,599	1,742,569	0.1%
India	2,552	41,469,499	< 0.1%
New Zealand	2,427	16,246	14.9%
Japan	2,195	2,730,828	< 0.1%
Hong Kong	1,853	–	–
France	1,712	18,634,317	< 0.1%
Estonia	1,681	344,060	0.4%
Netherlands	1,562	4,420,834	< 0.1%
Puerto Rico	1350	457,501	0.2%
Bangladesh	1,233	1,811,987	< 0.1%
Poland	1,219	4,925,158	< 0.1%
Spain	1,184	10,100,109	< 0.1%
Brazil	1,121	25,348,797	< 0.1%
Thailand	1,106	2,447,964	< 0.1%
Saudi Arabia	1,090	687,264	0.1%
Egypt	1,072	425,911	0.2%
Italy	1,063	10,983,116	< 0.1%

Nations providing one thousand or more specimens are listed. The numbers of specimens and cases were obtained from different data sources (NCBI Virus SARS-CoV-2 Data Hub and WHO Coronavirus Dashboard databases, respectively). Therefore, these specimens are not necessarily included in the number of cases

ISSN: 2730-6844